Personalized treatment for H. pylori infection in veterans
Part of Digestive system, Infections clinical trials.
This study compares a treatment plan based on your genes to the standard treatment for H. pylori, a stomach infection that can cause ulcers. The goal is to see which approach works better and has fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a veteran
- You have an active H. pylori infection confirmed by a stool antigen test within the last 4 weeks
- You have not been treated for H. pylori before
- You can stop taking acid-reducing medications (PPIs) for 2 weeks after treatment
- You do not have severe stomach problems or other major health issues that might interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a personalized treatment approach to the standard one for H. pylori infection. If you are scheduled for an upper endoscopy and need biopsies, you may be able to join.
This study tests whether a 14-day treatment with bismuth and four drugs, chosen based on lab tests showing which antibiotics still work, can clear an extremely stubborn H. pylori infection that hasn't gone away after at least two prior treatments.
This study helps people whose H. pylori stomach infection didn't go away after their first round of antibiotics. Researchers will test your stool to find which antibiotics work best, then prescribe a personalized treatment plan.
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.
This study tests a three-medicine combination (bismuth, tetracycline, and rabeprazole) as a first treatment to get rid of an H. pylori infection, a common stomach bacteria that can cause ulcers and other problems. The aim is to see if this treatment works well and is safe, so it might help you clear the infection and improve your stomach health.
Hear when a new Helicobacter Pylori trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.